On the recordJanuary 23, 2017
After questioning about 20 doctors and research institutions, it looks like problems with transparency are everywhere.
Source
congress.govEditor's note · Context
Grassley highlights widespread transparency issues in financial relationships between doctors and drug companies.
Share & report
More from Chuck Grassley
Apr 2, 2025
Congress has for too long delegated its clear authority to regulate interstate and foreign commerce to the executive branch.
Apr 30, 2025
Mr. President, April is National Donate Life Month. This is a month to raise awareness about the lifesaving importance of organ donation. There happen to be over 103,000 Americans on the national organ transplant waiting list. We should…
Apr 8, 2025
Mr. President, we are in the middle of what is known as March Madness. I am not talking about budget reconciliation or tax season; I am here to congratulate and say thank you to our outstanding student athletes who have competed their…
Apr 29, 2025
Mr. President, on Maundy Thursday, the Lord called home one of Iowa's best and brightest civic leaders and a beloved husband and father. A native son of northwest Iowa, Jay Byers passed away at age 54. Maundy is derived from the Latin term…
Other voices in this conversation
